Favorable Outcome For Patients With Lymphoid Malignancies Following Allogeneic Stem Cell Transplantation Using Fludarabine Treosulfan, Compared With Other Reduced Intensity Conditioning Regimen

被引：0
|
作者：
Yerushalmi, Ronit
Shem-Tov, Noga
Volchek, Yulia
Danylesko, Ivetta
Avigdor, Abraham
Nagler, Arnon
Shimoni, Avichai
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.3380.3380
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3380
引用
收藏
页数：2
相关论文
共 50 条
  • [1] FAVORABLE OUTCOME FOR PATIENTS WITH LYMPHOID MALIGNANCIES FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION USING FLUDARABINE TREOSULFAN, COMPARED WITH OTHER REDUCED INTENSITY CONDITIONING REGIMENS
    Yerushalmi, R.
    Shem-Tov, N.
    Volchek, Y.
    Danylesko, I.
    Avigdor, A.
    Nagler, A.
    Shimoni, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S175 - S175
  • [2] Favorable Outcome in Patients with Lymphoid Malignancies Following Allogeneic Stem Cell Transplantation Using Fludarabine and Treosulfan As the Preparative Regimen
    Yerushalmi, Ronit
    Shimoni, Avichai
    Shem-Tov, Noga
    Volchek, Yulia
    Avigdor, Abraham
    Nagler, Arnon
    BLOOD, 2012, 120 (21)
  • [3] Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies
    R Yerushalmi
    N Shem-Tov
    I Danylesko
    A Avigdor
    A Nagler
    A Shimoni
    Bone Marrow Transplantation, 2015, 50 : 1526 - 1535
  • [4] Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies
    Yerushalmi, R.
    Shem-Tov, N.
    Danylesko, I.
    Avigdor, A.
    Nagler, A.
    Shinnoni, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 (12) : 1526 - 1535
  • [5] Fludarabine and treosulfan; a novel reduced-toxicity regimen for allogeneic stem cell transplantation (SCT) in patients with lymphoid malignancies
    Yerushalmi, R.
    Shem-Tov, N.
    Volchek, Y.
    Avigdor, A.
    Nagler, A.
    Shimoni, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S220 - S220
  • [6] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Chichra, Akanksha
    Nayak, Lingaraj
    Kothari, Rushabh
    Kalantri, Siddhesh
    Bonda, Avinash
    Gokarn, Anant
    Punatar, Sachin
    Mirgh, Sumeet
    Jindal, Nishant
    Bagal, Bhausaheb
    Kannan, Sadhana
    Mathew, Libin
    Khattry, Navin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (01) : 71 - 79
  • [7] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Akanksha Chichra
    Lingaraj Nayak
    Rushabh Kothari
    Siddhesh Kalantri
    Avinash Bonda
    Anant Gokarn
    Sachin Punatar
    Sumeet Mirgh
    Nishant Jindal
    Bhausaheb Bagal
    Sadhana Kannan
    Libin Mathew
    Navin Khattry
    International Journal of Hematology, 2024, 119 : 71 - 79
  • [8] Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation
    Nihtinen, A
    Volin, L
    Juvonen, E
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
  • [9] Treosulfan and fludarabine:: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation
    Casper, J
    Knauf, W
    Kiefer, T
    Wolff, D
    Steiner, B
    Hammer, U
    Wegener, R
    Kleine, HD
    Wilhelm, S
    Knopp, A
    Hartung, G
    Dölken, G
    Freund, M
    BLOOD, 2004, 103 (02) : 725 - 731
  • [10] Reduced-intensity conditioning with treosulfan and fludarabine prior to allogeneic stem cell transplantation in multiple myeloma patients
    Schmidt-Hieber, M
    Casper, J
    Trenschel, R
    Andreesen, R
    Einsele, H
    Kanz, L
    Fauser, A
    Uharek, L
    Thiel, E
    Blau, I
    BONE MARROW TRANSPLANTATION, 2006, 37 : S195 - S196
12345